Učitavanje...
Biosimilars in India; Current Status and Future Perspectives
Many key biologics are scheduled to lose their patent by the year 2020, which will provide the opportunity to other biopharmaceutical companies to develop the similar biologics. Biosimilar or similar biologic used has increased in the recent year following the approval of the first biosimilar in ear...
Spremljeno u:
| Izdano u: | J Pharm Bioallied Sci |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Medknow Publications & Media Pvt Ltd
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6394151/ https://ncbi.nlm.nih.gov/pubmed/30906134 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/jpbs.JPBS_167_18 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|